You can search publications & resources by category, year of publication, type of publication & author.

— Latest Publications

  • Noy, S. Devlin, M.
    Housing, Health and the Well-being of Children.
    Ministry of Social Development. Wellington, New Zealand
  • Environmental burden of disease from unsafe and substandard housing, New Zealand, 2010-2017.
    Bulletin of the World Health Organization
    99, 259-270.
  • Ürge-Vorsatz, D.
    1.5°C of Global Warming: Can We Still Get There? Insights from the Urban Development Sector.
    In L. Grant, H. Viggers & P. Howden-Chapman (Eds.), Improving Buildings, Cutting Carbon.
    Wellington, New Zealand: Steele Roberts, Aotearoa
  • Submission on Transforming transport and cities in NZ: a note for the Climate Change Commission’s engagements on transport and urban form.
    New Zealand Centre for Sustainable Cities.
    Wellington, New Zealand.
  • Evaluating natural experiments to measure the co-benefits of urban policy interventions to reduce carbon emissions in New Zealand.
  • Hasan, M. A. Frame, D. J.
    Acceptability of Transport Emissions Reduction Policies: A Multi-Criteria Analysis.
    Renewable and Sustainable Energy Reviews,
    133, 110298.
  • Barthow, C. Hood, F. McKinlay, E. Hilder, J. Cleghorn, C. Huthwaite, M. Weatherall, M. Parry-Strong, A. Pullon, S. Gray, B. Wickens, K. Krebs, J.
    Food 4 Health - He Oranga Kai: Assessing the efficacy, acceptability and economic implications of Lactobacillus rhamnosus HN001 and β-glucan to improve glycated haemoglobin, metabolic health, and general well-being in adults with pre-diabetes: study proto
    Trials
    29;20(1):464, doi: 10.1186/s13063-019-3553-7
  • White, M.
    Healthy homes initiative: Initial analysis of health outcomes.
    Motu Note #37, Motu Economic and Public Policy Research, Wellington, New Zealand
  • Slykerman, R.F. Coomarasamy, C. Wickens, K. Thompson, J.M.D. Stanley, T.V. Barthow, C. Kang, J. Mitchell, E.A.
    Exposure to antibiotics in the first 24 months of life and neurocognitive outcomes at 11 years of age.
    Psychopharmacology
    (Berl). 2019; 36(5):1573-8